Ying Du
Chief Executive Officer bij ZAI LAB LIMITED
Vermogen: 2 M $ op 31-03-2024
Profiel
Ying Du, oprichter van Zai Lab Ltd., Hutchison MediPharma Ltd. en Zai Venture Partners, is een ondernemer die de positie bekleedt van Chairman & Chief Executive Officer bij Zai Lab Ltd. en General Partner bij Zai Venture Partners (een dochteronderneming van Zai Lab Ltd.). Dr. Du zit ook in de raad van bestuur van Eden Biologics, Inc. In het verleden bekleedde Dr. Du de functies van Chief Executive Officer bij Hutchison MediPharma Ltd., Chief Scientific Officer bij Hutchison China MediTech Ltd., Executive Vice President-Healthcare Investment bij Hutchison Whampoa (China) Ltd. en Venture Partner bij Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du is gepromoveerd aan de Universiteit van Cincinnati (Ohio) en heeft een bachelorgraad van de Jilin Universiteit.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZAI LAB LTD.
0.11% | 03-04-2024 | 1 107 972 ( 0.11% ) | 2 M $ | 31-03-2024 |
Actieve functies van Ying Du
| Bedrijven | Functie | Begin |
|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 01-04-2014 |
| JHL BIOTECH, INC. | Director/Board Member | 17-12-2012 |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Founder | 01-01-2017 |
Eerdere bekende functies van Ying Du
| Bedrijven | Functie | Einde |
|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Private Equity Investor | - |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Corporate Officer/Principal | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Opleiding van Ying Du
| University of Cincinnati (Ohio) | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Finance |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Finance |
